arrow
A

Akihiro Sakai

Tokai University
H指数:33
被引数:4,833

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A self-amplifying nerve-fibroblast circuit drives colorectal cancer progression

自放大神经-成纤维细胞回路驱动结直肠癌进展

2026-07-240
PRE
The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapy

HER2-Low表达在涎腺导管癌中的影响:临床病理特征、生存结局及其与雄激素受体靶向治疗的关联

2025-06-010
PRE
PD-L1 expression as a predictive biomarker in patients with recurrent or metastatic salivary gland carcinoma treated with pembrolizumab

PD-L1表达作为使用pembrolizumab治疗的复发或转移性唾液腺癌患者的预测生物标志物

2024-08-270
OAAI
The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinoma

涎腺导管癌自主神经的临床病理及预后意义

2024-07-230
PRE
Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinoma

肿瘤免疫微环境在涎腺导管癌中的预后价值及临床病理作用

2023-07-194
PRE
Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling

通过综合分子谱分析鉴定涎腺导管癌的新型预后和预测生物标志物

2022-11-047
OAAI
Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma

HER2-targeted或雄激素剥夺疗法在涎腺导管癌中的生存益处

2022-09-0619
OAAI
ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9
2022-07-021
PRE
Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9
2022-06-203
PRE
The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis
2022-03-01101
OA
The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy

EZH2和H3K27me3表达作为涎腺导管癌患者临床预后预测指标的作用: 一项大型系列研究,重点是雄激素阻断和HER2-Targeted联合治疗的相关性

2022-02-0315
OAAI
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers

HPV E2,E4,E5驱动HPV阳性癌症的替代致癌途径

2020-08-2674
OAAI